Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386,127,219
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
65,288,038
-
Shares change
-
-1,192,006
-
Total reported value, excl. options
-
$391,634,950
-
Value change
-
-$13,617,286
-
Put/Call ratio
-
70%
-
Number of buys
-
85
-
Number of sells
-
-55
-
Price
-
$6.00
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2020
179 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q4 2020.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65,288,038 shares
of 386,127,219 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,577,959 shares), Indaba Capital Management, L.P. (5,530,600 shares), PRIMECAP MANAGEMENT CO/CA/ (5,433,843 shares), Neuberger Berman Group LLC (4,644,554 shares), ORBIMED ADVISORS LLC (3,892,346 shares), VANGUARD GROUP INC (3,476,310 shares), FMR LLC (2,944,200 shares), Atom Investors LP (2,911,002 shares), MILLENNIUM MANAGEMENT LLC (1,663,087 shares), and Asymmetry Capital Management, L.P. (1,544,904 shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.